Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheeba K Thomas

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
American Journal of Hematology|October 10, 2018
Melphalan-based autologous transplant in octogenarian multiple myeloma patientsNeeraj Y Saini, Romil Patel, Ankur Varma, et al.
Leukemia|March 31, 2025
Zanubrutinib in Bing Neel syndrome: efficacy and tolerabilityAnne-Marie L Becking, Johannes P M van de Mortel, Oliver Tomkins, et al.
Leukemia|March 28, 2018
Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myelomaXiaohui Zhang, Hans C Lee, Fazal Shirazi, et al.
British Journal of Haematology|March 6, 2024
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantationKamal Alzahrani, Oren Pasvolsky, Zhongya Wang, et al.
Transplantation and Cellular Therapy|September 27, 2023
Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple MyelomaEthan P Damron, Muzaffar H Qazilbash, Penny Q Fang, et al.
British Journal of Haematology|June 28, 2023
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplantOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
American Journal of Hematology|September 24, 2021
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity-score matched analysisRomil Patel, Junsheng Ma, Qaiser Bashir, et al.
Blood Advances|October 7, 2020
Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MMNeeraj Saini, Qaiser Bashir, Denái R Milton, et al.
Blood Cancer Journal|June 5, 2026
D-VRD induction and autologous transplant in patients ≥70 yearsOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Blood Cancer Journal|May 17, 2024
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantationOren Pasvolsky, Zhongya Wang, Denái R Milton, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
American Journal of Hematology|October 10, 2018
Melphalan-based autologous transplant in octogenarian multiple myeloma patientsNeeraj Y Saini, Romil Patel, Ankur Varma, et al.
Leukemia|March 31, 2025
Zanubrutinib in Bing Neel syndrome: efficacy and tolerabilityAnne-Marie L Becking, Johannes P M van de Mortel, Oliver Tomkins, et al.
Leukemia|March 28, 2018
Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myelomaXiaohui Zhang, Hans C Lee, Fazal Shirazi, et al.
British Journal of Haematology|March 6, 2024
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantationKamal Alzahrani, Oren Pasvolsky, Zhongya Wang, et al.
Transplantation and Cellular Therapy|September 27, 2023
Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple MyelomaEthan P Damron, Muzaffar H Qazilbash, Penny Q Fang, et al.
British Journal of Haematology|June 28, 2023
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplantOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
American Journal of Hematology|September 24, 2021
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity-score matched analysisRomil Patel, Junsheng Ma, Qaiser Bashir, et al.
Blood Advances|October 7, 2020
Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MMNeeraj Saini, Qaiser Bashir, Denái R Milton, et al.
Blood Cancer Journal|June 5, 2026
D-VRD induction and autologous transplant in patients ≥70 yearsOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Blood Cancer Journal|May 17, 2024
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantationOren Pasvolsky, Zhongya Wang, Denái R Milton, et al.
Pageof 12